VMI
MYOV

VHCP Management II’s Myovant Sciences Ltd. MYOV Stock Holding History

VHCP Management II’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.19M Buy
+76,768
New +$774K 0.31% 17

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VHCP Management II's MYOV Position: Q4 2019 in Review

VHCP Management II opened a new position in Myovant Sciences Ltd. (MYOV) in Q4 2019: 76,768 shares worth $1.19M. The stake represents 0.31% of the portfolio and ranks #17 among its holdings.

77 funds tracked by Wall St. Rank hold MYOV as of Q4 2019.

  • VHCP Management II held 76,768 shares of Myovant Sciences Ltd. worth $1.19M as of Q4 2019.
  • Myovant Sciences Ltd. was a new VHCP Management II position in Q4 2019.
  • Myovant Sciences Ltd. made up 0.31% of VHCP Management II's portfolio in Q4 2019, its #17 holding.
  • 77 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.